Novartis Aktie
110,95
EUR
-1,15
EUR
-1,03
%
102,12
CHF
-1,96
CHF
-1,88
%
Werbung
Novartis Aktie Analyse
| 23.03.17 | Novartis buy | Société Générale Group S.A. (SG) | |
| 09.03.17 | Novartis buy | Jefferies & Company Inc. | |
| 08.03.17 | Novartis buy | Société Générale Group S.A. (SG) | |
| 17.02.17 | Novartis buy | Jefferies & Company Inc. | |
| 30.01.17 | Novartis buy | HSBC | |
| 25.01.17 | Novartis Outperform | Bernstein Research | |
| 25.01.17 | Novartis buy | Baader Bank | |
| 19.12.16 | Novartis buy | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 13.12.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 13.12.16 | Novartis buy | HSBC | |
| 18.11.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 08.11.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.10.16 | Novartis buy | Baader Wertpapierhandelsbank | |
| 26.10.16 | Novartis Outperform | Credit Suisse Group | |
| 26.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 24.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.10.16 | Novartis Outperform | Bernstein Research | |
| 13.10.16 | Novartis buy | Jefferies & Company Inc. | |
| 10.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 13.09.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 11.08.16 | Novartis buy | Kepler Cheuvreux | |
| 04.08.16 | Novartis buy | Jefferies & Company Inc. | |
| 21.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 20.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 20.07.16 | Novartis Outperform | Bernstein Research | |
| 18.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 14.07.16 | Novartis buy | Jefferies & Company Inc. | |
| 13.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 07.07.16 | Novartis buy | Kepler Cheuvreux | |
| 26.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 23.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 11.05.16 | Novartis buy | Jefferies & Company Inc. | |
| 26.04.16 | Novartis Outperform | Bernstein Research | |
| 26.04.16 | Novartis buy | HSBC | |
| 25.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 21.04.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 13.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 05.04.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.03.16 | Novartis buy | HSBC | |
| 22.02.16 | Novartis buy | Jefferies & Company Inc. | |
| 19.02.16 | Novartis kaufen | JP Morgan Chase & Co. | |
| 01.02.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.01.16 | Novartis buy | HSBC | |
| 28.01.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 25.01.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 22.01.16 | Novartis buy | UBS AG | |
| 19.01.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.01.16 | Novartis buy | Jefferies & Company Inc. | |
Werbung
Werbung